Literature DB >> 26889260

Anti-leucine-rich glioma-inactivated 1 limbic encephalitis: A case report and literature review.

Jingyao Liu1, Min Li1, Guibo Li2, Chunkui Zhou1, Rensheng Zhang1.   

Abstract

This study describes the case of a 41-year-old woman admitted for anterograde memory loss, right facial grimacing and right arm posturing that had begun 1 month previously. Cranial magnetic resonance-diffusion weighted imaging and -fluid-attenuated inversion recovery imaging revealed a hyperintense signal in the left hippocampus and right basal ganglia, but no contrast enhancement. An electroencephalogram revealed rhythmic sharp and slow waves and rhythmic θ build-ups in the left temporal area. Single-photon emission computed tomography showed increased regional blood flow perfusion in the left cerebral frontal lobe and the right basal ganglia. The cerebrospinal fluid was normal, with the exception of the presence of leucine-rich glioma-inactivated 1 (LGI1) antibodies, and LGI1 antibodies were also found in the blood serum. The presence of the antibodies, the faciobrachial dystonic seizures (FBDSs) and the memory loss indicated limbic encephalitis. After 3 months of immunotherapy, the patient was free from epileptic seizures and had undergone a partial memory restoration. FBDSs alone justify the immediate initiation of immunotherapy, even prior to laboratory confirmation of the disease, as early treatment limits the duration of the illness.

Entities:  

Keywords:  faciobrachial dystonic seizures; leucine-rich glioma-inactivated 1; limbic encephalitis

Year:  2015        PMID: 26889260      PMCID: PMC4727108          DOI: 10.3892/etm.2015.2866

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  17 in total

1.  Full recovery of agrypnia associated with anti-Lgi1 antibodies encephalitis under immunomodulatory treatment: a case report with sequential polysomnographic assessment.

Authors:  Laure Peter-Derex; Perrine Devic; Véronique Rogemond; Sylvain Rheims; François Mauguière; Jérôme Honnorat
Journal:  Sleep Med       Date:  2012-03-19       Impact factor: 3.492

2.  LGI-1-positive limbic encephalitis: a clinicopathological study.

Authors:  Jörg Schultze-Amberger; Debora Pehl; Werner Stenzel
Journal:  J Neurol       Date:  2012-05-31       Impact factor: 4.849

Review 3.  Autoimmune epilepsies.

Authors:  Sarosh R Irani; Christian G Bien; Bethan Lang
Journal:  Curr Opin Neurol       Date:  2011-04       Impact factor: 5.710

Review 4.  The diagnosis and treatment of limbic encephalitis.

Authors:  F Asztely; E Kumlien
Journal:  Acta Neurol Scand       Date:  2012-06-19       Impact factor: 3.209

5.  Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia.

Authors:  Eric Lancaster; Maartje G M Huijbers; Vered Bar; Anna Boronat; Andrew Wong; Eugenia Martinez-Hernandez; Christina Wilson; Dina Jacobs; Meizan Lai; Russell W Walker; Francesc Graus; Luis Bataller; Isabel Illa; Sander Markx; Kevin A Strauss; Elior Peles; Steven S Scherer; Josep Dalmau
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

Review 6.  NMDA receptor antibody encephalitis.

Authors:  Sarosh R Irani; Angela Vincent
Journal:  Curr Neurol Neurosci Rep       Date:  2011-06       Impact factor: 5.081

7.  [Limbic encephalitis with severe sleep disorder associated with voltage-gated potassium channels (VGKCs) antibodies].

Authors:  P Montiel; F Sellal; C Clerc; P Richard; M Bataillard
Journal:  Rev Neurol (Paris)       Date:  2008-02-20       Impact factor: 2.607

Review 8.  Limbic encephalitis and variants: classification, diagnosis and treatment.

Authors:  Erdem Tüzün; Josep Dalmau
Journal:  Neurologist       Date:  2007-09       Impact factor: 1.398

9.  Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype.

Authors:  Sarosh R Irani; Charlotte J Stagg; Jonathan M Schott; Clive R Rosenthal; Susanne A Schneider; Philippa Pettingill; Rosemary Pettingill; Patrick Waters; Adam Thomas; Natalie L Voets; Manuel J Cardoso; David M Cash; Emily N Manning; Bethan Lang; Shelagh J M Smith; Angela Vincent; Michael R Johnson
Journal:  Brain       Date:  2013-09-06       Impact factor: 13.501

10.  Anti-LGI1 Limbic Encephalitis Presented with Atypical Manifestations.

Authors:  Jung-Ju Lee; Soon-Tae Lee; Keun-Hwa Jung; Kon Chu; Sang Kun Lee
Journal:  Exp Neurobiol       Date:  2013-12-31       Impact factor: 3.261

View more
  1 in total

1.  Clinical features of limbic encephalitis with LGI1 antibody.

Authors:  Meiling Wang; Xiaoyu Cao; Qingxin Liu; Wenbin Ma; Xiaoqian Guo; Xuewu Liu
Journal:  Neuropsychiatr Dis Treat       Date:  2017-06-16       Impact factor: 2.570

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.